27 results on '"Hardtstock F"'
Search Results
2. EPH189 Assessing Changes in the Number and Profile of New Cases of Bacterial Sexually Transmitted Infections From 2018-2021: A Descriptive Analysis of German Claims Data
3. EE391 Impact of the COVID-19 Pandemic on the Healthcare Resource Use of People With Newly Diagnosed Mood/Affective Disorder
4. HPR147 Evaluating the Misdiagnosis of Add in Patients With Prior History of Depression: A Claims Data Study in Germany
5. EPH106 Evaluating Changes in the Diagnostic Setting and Treatment of Bacterial Sexually Transmitted Infections in Germany During COVID-19: A Descriptive Analysis of German Claims Data From 2018-2021
6. P33 Evaluating the Impact of the COVID-19 Pandemic on the Diagnosis and Staging of New Breast Cancer Cases: A Retrospective Analysis of Medical Chart Data from the United States
7. P15 Transcatheter versus Surgical Aortic Valve Replacement: A Real-World Comparison of Clinical Outcomes Based on a German Claims Dataset
8. P64 Evaluating the Impact of the COVID-19 Pandemic on Mortality after Myocardial Infarctions Hospitalization in Germany
9. RWD173 Treatment Patterns, Healthcare Resource Utilization (HCRU), and Associated Costs in Patients with Newly Diagnosed Metastatic Urothelial Carcinoma (MUC): A Real-World Analysis of German Claims Data
10. PCN74 Comparing Healthcare Costs in the Last Year of Life Among Patients with Different Cancer Indications in Germany
11. PCN76 Evaluating Trends In Direct Healthcare Costs In The Last Year Of Life Among Patients With Lung Cancer In Germany
12. PMU80 Prediction Of Clinical Outcomes, Healthcare Resource Use (HCRU) And Costs Using Secondary Data Sources: A Targeted Literature Review Of The Recent Publications
13. PMU8 Health Care Spending And The Pareto Principle - The Minority That Causes The Majority
14. PGI57 NON-BIOLOGIC TREATMENT OF GERMAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: ASSESSMENT OF HEALTH CARE RESOURCE USE AND COST ASSOCIATED WITH DISEASE ACTIVITY
15. PRS69 TREATMENT OF COPD PATIENTS IN GERMANY AND THE NEED FOR THERAPY ESCALATION: A CLAIMS DATA ANALYSIS
16. ON7 TIME-TO-TREATMENT DISCONTINUATION (TTD) AS A PRAGMATIC PREDICTOR OF OVERALL SURVIVAL (OS) IN FIRST-LINE ADVANCED NON-SMALL CELL LUNG CANCER (ANSCLC) - REAL-WORLD PERSPECTIVE
17. PMU149 DIRECT COSTS ASSOCIATED WITH THE TREATMENT OF CANCER PATIENTS: DID THEY INCREASE IN RECENT YEARS?
18. PCN400 ONCOLOGY-RELATED HTA DECISIONS IN GERMANY, FRANCE, SPAIN AND THE UK: ASSESSMENT OF SIMILARITIES AND DIFFERENCES
19. PRS70 APPLYING DIFFERENT MEASURES TO ASSESS PATIENTS' NON-ADHERENCE: RESULTS OF A LINKED DATA STUDY OF PATIENTS WITH ASTHMA IN GERMANY
20. PRS59 ADAPTION OF THE ADHERENCE BARRIERS QUESTIONNAIRE (ABQ) FOR USE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
21. HT3 WHAT INFLUENCES THE PROBABILITY TO BE SUCCESSFUL IN AN ONCOLOGY HTA? AN ANALYSIS OF ONCOLOGY HTA DECISIONS IN GERMANY, SPAIN AND THE UK
22. PND122 HEALTHCARE RESOURCE UTILIZATIONS AND COSTS AMONG PATIENTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS - A COMPARISON OF PATIENTS WITH AND WITHOUT UPPER LIMB FUNCTION IMPAIRMENT
23. PCN398 THE IMPORTANCE OF DIFFERENT ENDPOINTS IN ONCOLOGY-RELATED HEALTH TECHNOLOGY ASSESSMENTS: RESULTS OF A REVIEW OF DECISIONS IN GERMANY
24. PNS416 A MODEL-BASED STANDARDISATION APPROACH TO INCREASE GENERALISABILITY OF CLAIMS DATA ANALYSES: THE EXAMPLE OF GERMAN CLAIMS DATA
25. PCN390 ANALYSIS OF INDIRECT TREATMENT COMPARISONS IN ONCOLOGY-RELATED HTA DECISIONS IN GERMANY
26. PCN267 PREVALENCE OF DIFFERENT TYPES OF CANCER IN GERMANY: A COMPARATIVE ANALYSIS OF CLAIMS DATA AND REGISTRY DATA IN GERMANY
27. PIN145 PATIENT PREFERENCES TOWARDS DRUG TREATMENT OF CHRONIC HEPATITIS B - A DISCRETE CHOICE EXPERIMENT IN GERMANY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.